Health 13 Mar 2026 Patrys acquire Perth biotech for delirium drug Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn A world-first antipsychotic injectable drug developed in Perth will accelerate its path to market after the company behind it, Reliis, was acquired by a Melbourne biotechnology developer.
